NCT07010120 2025-06-13
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT05516589 2025-05-22
neoCHANCE-2
West China Hospital
Phase 2 Completed
NCT01783587 2025-05-01
Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT06741982 2024-12-19
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
West China Hospital
Phase 1 Recruiting
NCT06648096 2024-11-20
AFAN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1/2 Recruiting
NCT03088059 2023-11-03
UPSTREAM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT01824823 2023-06-28
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT01415674 2022-02-02
PREDICTOR
UNICANCER
Phase 2 Completed
NCT01427478 2021-06-01
BIBW2992ORL
Centre Leon Berard
Phase 3 Completed
NCT01732640 2018-07-26
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Terminated
NCT01538381 2018-07-09
Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT02216617 2017-10-27
TAPIS
Groupe Oncologie Radiotherapie Tete et Cou
Phase 1 Completed